Currently Enrolling Trials
Viroptic Oththalmic Solution (trifluridine) 1% has been approved for use in children (ages 6+) as a treatment for inflammation of the cornea caused by the herpes simplex virus. The antiviral agent was previously approved for use in adults.
Approval Date: 1998-02-01
Company Name: King Pharmaceuticals